- Home
- AZTA vs FRNM Comparison
AZTA vs FRNM Comparison
Compare AZTA & FRNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZTA | FRNM |
|---|---|---|
| Founded | 1978 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 1996 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AZTA | FRNM |
|---|---|---|
| Price | $33.58 | $13.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $40.60 | N/A |
| AVG Volume (30 Days) | 651.3K | ★ 803.9K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $593,821,000.00 | N/A |
| Revenue This Year | $6.99 | N/A |
| Revenue Next Year | $5.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.93 | $9.97 |
| 52 Week High | $41.73 | $12.30 |
Technical Indicators
Market Signals| Indicator | AZTA | FRNM |
|---|---|---|
| Relative Strength Index (RSI) | 68.67 | 63.40 |
| Support Level | $28.89 | $11.40 |
| Resistance Level | $38.21 | N/A |
| Average True Range (ATR) | 1.40 | 0.69 |
| MACD | 0.18 | 0.14 |
| Stochastic Oscillator | 84.70 | 95.58 |
Price Performance
Historical ComparisonAbout AZTA Azenta Inc.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.